WashU trial evaluates effectiveness of COVID-19 vaccines for people taking immunosuppressants

Alfred Kim, MD, PhD
View Content

The trial wants to see how the vaccine interacts with people on immunosuppressants

ST. LOUIS — For people on immunosuppressants, there are still a lot of unknowns when it comes to the COVID-19 vaccine.

They don’t know how much protection they will have.

Washington University said these patients were not included in the large COVID-19 vaccine trials and the drugs they are taking may blunt the body’s antibody response to vaccines.